Ebola outbreak: First Briton to contract deadly virus now in London hospital isolation unit
William Pooley will not be treated with experimental drug used on the two Americans who have now recovered
The first British person known to have contracted the deadly Ebola virus has been flown to London and is being treated by doctors.
He has been named as William Pooley, 29, a nurse who had travelled to Sierra Leone as a volunteer to help care for the victims of the Ebola outbreak. He was identified by Dr Robert Garry, an American scientist who worked with him at the Kenema Government Hospital in the south-east of Sierra Leone.
A specially equipped military aircraft flew Mr Pooley from Sierra Leone’s main airport in Lungi to the UK on Sunday, landing at the RAF base in Northolt, where he was then transferred under police escort to the Royal Free Hospital in Hampstead, London.
The hospital has Britain’s only high-security infectious-disease unit, and Mr Pooley, who is described as “not currently seriously unwell,” is being treated in a specialist isolation unit containing a tent made of plastic and rubber that separates the patient from medical staff while ensuring he can be observed.
A ventilation system attached to the unit means the air inside the tent is cleaned before being released into the atmosphere.
The Ebola outbreak has killed nearly 1,500 people since March, when the first reported cases from Guinea spread across the country and borders into Liberia and Sierra Leone. There is no cure for the disease and the current fatality rate is believed to be at 90%.
Despite the recovery of the two American humanitarian workers, who were flown back to the States after contracting Ebola in Liberia, Mr Pooley will not be treated with the same drugs.
The high level isolation apparatus at the Royal Free The Americans were treated with an experimental drug in hospital in Atlanta. The drug is yet to be tested through full clinical and human trials, and it is not known to what extent the drug treatment contributed to the pair’s recovery.
ZMapp, the American manufacturer of the experimental treatment, said the supplies of the drug have been exhausted since the later treatment of three African doctors in Liberia, but the Department of Health said it is attempting to source any remaining doses available.
Professor John Watson, deputy chief medical officer, insisted that “the overall risk to the public in the UK remains very low”.
- 1 10 ways we damage our teeth – without realising
- 2 Fifa corruption arrests: Nike reported to be 'multinational sportswear company' at centre of bribery claims over Brazil shirt deal
- 3 Facebook Messenger sends 'creepily' precise location data, as revealed by Marauders Map Chrome extension
- 5 Photo of wedding guest proposing to girlfriend in front of bride and groom goes viral
Hopes raised for treatment of severe amnesia after scientists retrieve lost memory – using light
Playboy model April Summers speaks out about being a victim of a voyeuristic sex crime
Poorest part of London is wealthier than the richest parts of Northern Ireland and Wales
British tourists complain that impoverished boat migrants are making holidays 'awkward' in Kos
How to live to be really old
EU referendum: David Cameron's rules are a 'democratic disgrace', says French-born Scottish politician set to be denied a vote
SNP fury as HS2 finds 'no business case' for taking fast train service to Scotland
Australian man punched in the face for defending Muslim women from abuse on train
A nation of inequality: How the UK is failing to feed its most vulnerable people
David Starkey 'tells Amal Clooney to shut up and stop over-promoting human rights'
EU referendum: David Cameron to deny EU migrants and under-18s the chance to vote
£16000 - £18000 per annum: Recruitment Genius: One of the UK's leading Solar P...
£18000 per annum: Recruitment Genius: This organisation is changing the way at...
Negotiable: Recruitment Genius: A Digital Web Designer is required to join a f...
Negotiable: Recruitment Genius: This is a fantastic opportunity to develop an ...